TriSalus Life Sciences, Inc. (TLSIW) Operating margin 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) operating margin by fiscal year — reported operating income divided by reported revenue.
-59.7%FY2025 · since FY2022: -293.9% → -59.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.7% | +63.2 pp |
| FY2024 | -122.9% | +171.4 pp |
| FY2023 | -294.3% | -0.4 pp |
| FY2022 | -293.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →